Abivax S.A.
ABVX.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €421 | €427 | €807 | €493 |
| - Cash | €61 | €144 | €222 | €252 |
| + Debt | €99 | €96 | €113 | €55 |
| Enterprise Value | €459 | €379 | €698 | €297 |
| Revenue | €2 | €4 | €7 | €2 |
| % Growth | -49.7% | -41% | 202.3% | – |
| Gross Profit | €2 | €4 | €7 | €2 |
| % Margin | 100% | 100% | 100% | 83.2% |
| EBITDA | -€94 | -€92 | -€80 | -€90 |
| % Margin | -4,640.3% | -2,292.7% | -1,176.3% | -4,011% |
| Net Income | -€101 | -€95 | -€82 | -€96 |
| % Margin | -4,996.7% | -2,361.6% | -1,203% | -4,266.7% |
| EPS Diluted | -1.59 | -1.5 | -1.3 | -1.91 |
| % Growth | -6% | -15.4% | 31.9% | – |
| Operating Cash Flow | -€67 | -€70 | -€85 | -€70 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | -€67 | -€71 | -€85 | -€70 |